JP2020011967A5 - - Google Patents

Download PDF

Info

Publication number
JP2020011967A5
JP2020011967A5 JP2019159348A JP2019159348A JP2020011967A5 JP 2020011967 A5 JP2020011967 A5 JP 2020011967A5 JP 2019159348 A JP2019159348 A JP 2019159348A JP 2019159348 A JP2019159348 A JP 2019159348A JP 2020011967 A5 JP2020011967 A5 JP 2020011967A5
Authority
JP
Japan
Prior art keywords
preparation according
external preparation
permeation
acid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019159348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020011967A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020011967A publication Critical patent/JP2020011967A/ja
Publication of JP2020011967A5 publication Critical patent/JP2020011967A5/ja
Pending legal-status Critical Current

Links

JP2019159348A 2017-10-30 2019-09-02 爪白癬治療用の外用製剤 Pending JP2020011967A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017209136 2017-10-30
JP2017209136 2017-10-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019529667A Division JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤

Publications (2)

Publication Number Publication Date
JP2020011967A JP2020011967A (ja) 2020-01-23
JP2020011967A5 true JP2020011967A5 (enExample) 2021-12-02

Family

ID=66333195

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529667A Active JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤
JP2019159348A Pending JP2020011967A (ja) 2017-10-30 2019-09-02 爪白癬治療用の外用製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019529667A Active JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤

Country Status (14)

Country Link
US (1) US20210213002A1 (enExample)
EP (1) EP3705136A4 (enExample)
JP (2) JP6582158B1 (enExample)
KR (1) KR20200081432A (enExample)
CN (1) CN111295202B (enExample)
AU (1) AU2018358372A1 (enExample)
BR (1) BR112020008282A2 (enExample)
CA (1) CA3081163A1 (enExample)
IL (1) IL274100B2 (enExample)
MX (1) MX2020004491A (enExample)
RU (1) RU2020117569A (enExample)
SG (1) SG11202003820VA (enExample)
TW (1) TWI789448B (enExample)
WO (1) WO2019088005A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220119363A (ko) 2019-12-24 2022-08-29 가껭세이야꾸가부시기가이샤 에피나코나졸을 함유하는 의약
WO2022035031A1 (ko) * 2020-08-14 2022-02-17 비엘엔에이치 주식회사 백선의 예방 또는 치료용 약학적 조성물
KR102217617B1 (ko) * 2020-08-14 2021-02-19 비엘엔에이치 주식회사 백선의 예방 또는 치료용 약학적 조성물
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
EP4527399A1 (en) 2022-05-16 2025-03-26 Maruho Co., Ltd. Composition for treating ringworm
JPWO2025028651A1 (enExample) * 2023-08-02 2025-02-06
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
JPS58162514A (ja) * 1982-03-19 1983-09-27 Sumitomo Chem Co Ltd 外用ゲル製剤
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
EP0721349A1 (en) * 1993-09-29 1996-07-17 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutynin
CA2343284C (en) * 1998-09-10 2008-11-18 Ipr-Institute For Pharmaceutical Research Ag Topical application products
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
JP5061519B2 (ja) 2006-07-12 2012-10-31 大正製薬株式会社 抗真菌剤含有o/wエマルション組成物
HUE029707T2 (en) 2007-08-27 2017-03-28 Nihon Nohyaku Co Ltd Anti-fungal dermatitis
NL2003711C2 (en) * 2009-10-27 2011-04-28 Shield Mark B V Aqueous composition for topical application, method of preparation, uses and device.
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
JP5362128B2 (ja) 2011-01-30 2013-12-11 Meiji Seikaファルマ株式会社 外用抗真菌剤
US9364487B2 (en) * 2011-11-04 2016-06-14 Agile Therapeutics, Inc. Dermal delivery compositions and methods
RU2621615C2 (ru) * 2012-09-14 2017-06-06 Пола Фарма Инк. Фармацевтическая композиция, содержащая луликоназол
RU2694758C2 (ru) * 2012-12-20 2019-07-16 Раджив Бхушан Антимикробные композиции
JP6308137B2 (ja) * 2012-12-28 2018-04-11 大正製薬株式会社 皮膚適用製剤
CN103142458B (zh) * 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
CA3052643A1 (en) * 2013-11-22 2015-05-28 Bausch Health Ireland Limited Anti-infective methods, compositions, and devices
JP5623671B1 (ja) * 2014-07-23 2014-11-12 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP6469238B2 (ja) 2015-09-18 2019-02-13 科研製薬株式会社 ビアリール誘導体及びそれを含有する医薬
JP2017209136A (ja) 2016-05-23 2017-11-30 澁谷工業株式会社 電子線殺菌装置

Similar Documents

Publication Publication Date Title
US8268876B2 (en) Pharmaceutical composition for external use
DK2315581T3 (en) TOPICAL COMPOSITION FOR THE TREATMENT OF actinic keratosis
US20180185394A1 (en) Pharmaceutical tetracycline composition for dermatological use
JP2019108388A5 (enExample)
US20090137651A1 (en) Pharmaceutical composition for external use
TWI789448B (zh) 灰指甲治療用之外用製劑
DK2190425T3 (en) Topically applicable fungicidal agents for the treatment of nails
JP2018526325A5 (enExample)
JP5883886B2 (ja) 抗真菌組成物
JP5992324B2 (ja) 脂肪酸モノグリセリド組成物
JP2016503058A5 (enExample)
WO2019164984A1 (en) Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibiotics
JP2024544415A5 (enExample)
RU2017129893A (ru) Фармацевтическая композиция для местного применения
US10258560B1 (en) Composition for topical treatment of nail conditions
JP2022516859A5 (enExample)
JP2008534644A5 (ja) 2型糖尿病を治療または予防する組成物
RU2015129081A (ru) Гелевые композиции
JP2022516404A5 (enExample)
WO2009087005A4 (en) Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
JP2014156481A (ja) 核酸を有効成分とする外用剤組成物
NZ797565B2 (en) 1-amino-1-cyclopropanecarboxylic acid hydrochloride formulations
RU2019114202A (ru) Противомикробные составы для лечения ветеринарных инфекций копыт
JP2019043853A (ja) 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤
JP2015134738A (ja) 皮膚真菌症治療剤